NCT00398086 - Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 1, 2006

Primary Completion Date

September 1, 2008

Study Completion Date

December 1, 2010

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG

Gemcitabine

Administered by intravenous infusion over 30 minutes.

DRUG

Albumin-bound paclitaxel

Administered by intravenous infusion over 30 minutes.

Trial Locations (5)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore

Virigina Piper Cancer Institute, Minneapolis

South Texas Oncology & Hematology, San Antonio

Scottsdale Healthcare/Virginia Pipe Cancer Institute, Scottsdale

University of Alabama at Birmingham Comprehensive Cancer Ctr, Birmingham